For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Targeted Genetics Corporation

USPTO Granted Patents = 20

EPO Patents = 1

Forward Citations = 1,081

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Andrew Lawrence Feldhaus (5 out of 28 patents)

James Maurice Allen (4 out of 62 patents)

Barrie J Carter (3 out of 12 patents)

4. Ryan K Takeya (3 out of 3 patents)

5. Ian L Aranha (3 out of 3 patents)

6. Anthony M Stepan (3 out of 3 patents)

7. Haim Burstein (3 out of 3 patents)

8. Stephen D Lupton (3 out of 15 patents)

9. Victor Fung (2 out of 11 patents)

10. Edward M Atkinson, Iii (2 out of 8 patents)

11. Perry C Wilkins (2 out of 2 patents)

12. Thomas C Reynolds (2 out of 2 patents)

13. Dara H Lockert (2 out of 2 patents)

14. Carmel M Lynch (2 out of 2 patents)

15. Ralph Wilfred Paul (2 out of 3 patents)

20 patents: Sort by Forward Citations

1. 7749491 - Compounds and methods to enhance rAAV transduction (2010-07-06),

2. 7125717 - Metabolically activated recombinant viral vectors and methods for their preparation and use (2006-10-24),

3. 6995006 - Methods for generating high titer helper-free preparations of released recombinant AAV vectors (2006-02-07),

4. 6989264 - Methods for generating high titer helper-free preparations of released recombinant AAV vectors (2006-01-24),

5. 6936466 - Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors (2005-08-30),

6. 6924128 - Packaging cell lines for generation of high titers of recombinant AAV vectors (2005-08-02),

7. 6893865 - Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles (2005-05-17),

8. 6642051 - Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors (2003-11-04),

9. 6596535 - Metabolically activated recombinant viral vectors and methods for the preparation and use (2003-07-22),

10. 6593124 - Hybrid genes for expression of stimulatory factors in activated T cells (2003-07-15),

11. 6566118 - Methods for generating high titer helper-free preparations of released recombinant AAV vectors (2003-05-20),

12. 6541258 - AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors (2003-04-01),

13. 6537540 - Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders (2003-03-25),

14. 6346415 - Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors (2002-02-12),

15. 6316257 - Modified rapid expansion methods (“modified-REM”) for in vitro propagation of T lymphocytes (2001-11-13),

Targeted Genetics Corporation is a biotechnology company that focuses on developing gene therapy treatments for various diseases. With expertise in gene delivery systems and a strong commitment to research and innovation, Targeted Genetics aims to pioneer safe and effective therapeutic solutions. Through its cutting-edge technologies, the company aims to transform the field of medicine and improve patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

20 Patents

#92 in Seattle, WA

#333 in Washington

#15,857 in US

#30,327 in the World

Seattle, WA, United States of America

Targeted Genetics Corporation

Forward Citations = 1,081

33 inventors:

Andrew Lawrence Feldhaus (5 out of 28 patents)

James Maurice Allen (4 out of 62 patents)

Barrie J Carter (3 out of 12 patents)

4. Ryan K Takeya (3 out of 3 patents)

5. Ian L Aranha (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…